Rybojad M - Search Results

1

Incidence, risk factors, and severity of herpesvirus infections in a cohort of 121 patients with primary dermatomyositis and dermatomyositis associated with a malignant neoplasm.

Fardet L, Rybojad M, Gain M, Kettaneh A, Cherin P, Bachelez H, Dubertret L, Lebbe C, Morel P, Dupuy A. Fardet L, et al. Among authors: rybojad m. Arch Dermatol. 2009 Aug;145(8):889-93. doi: 10.1001/archdermatol.2009.152. Arch Dermatol. 2009. PMID: 19687419

2

Quality of abstracts in 3 clinical dermatology journals.

Dupuy A, Khosrotehrani K, Lebbé C, Rybojad M, Morel P. Dupuy A, et al. Among authors: rybojad m. Arch Dermatol. 2003 May;139(5):589-93. doi: 10.1001/archderm.139.5.589. Arch Dermatol. 2003. PMID: 12756095 Free article.

3

Prognostic value of blood eosinophilia in primary cutaneous T-cell lymphomas.

Tancrède-Bohin E, Ionescu MA, de La Salmonière P, Dupuy A, Rivet J, Rybojad M, Dubertret L, Bachelez H, Lebbé C, Morel P. Tancrède-Bohin E, et al. Among authors: rybojad m. Arch Dermatol. 2004 Sep;140(9):1057-61. doi: 10.1001/archderm.140.9.1057. Arch Dermatol. 2004. PMID: 15381544

4

Factors associated with underlying malignancy in a retrospective cohort of 121 patients with dermatomyositis.

Fardet L, Dupuy A, Gain M, Kettaneh A, Chérin P, Bachelez H, Dubertret L, Lebbe C, Morel P, Rybojad M. Fardet L, et al. Among authors: rybojad m. Medicine (Baltimore). 2009 Mar;88(2):91-97. doi: 10.1097/MD.0b013e31819da352. Medicine (Baltimore). 2009. PMID: 19282699 Free article.

5

Treatment of cutaneous sarcoidosis with thalidomide.

Nguyen YT, Dupuy A, Cordoliani F, Vignon-Pennamen MD, Lebbé C, Morel P, Rybojad M. Nguyen YT, et al. Among authors: rybojad m. J Am Acad Dermatol. 2004 Feb;50(2):235-41. doi: 10.1016/j.jaad.2003.07.006. J Am Acad Dermatol. 2004. PMID: 14726878 Clinical Trial.

6

ESHAP for primary cutaneous T-cell lymphomas: efficacy and tolerance in 11 patients.

Mebazaa A, Dupuy A, Rybojad M, Mouly F, Moulonguet I, Vignon-Pennamen MD, Rivet J, Janin A, Lebbé C, Dubertret L, Morel P, Bachelez H, Brice P. Mebazaa A, et al. Among authors: rybojad m. Hematol J. 2005;5(7):553-8. doi: 10.1038/sj.thj.6200570. Hematol J. 2005. PMID: 15692599

7

Long-term follow-up of non-HIV Kaposi's sarcoma treated with low-dose recombinant interferon alfa-2b.

Costa da Cunha CS, Lebbe C, Rybojad M, Agbalika F, Ferchal F, Rabian C, Vignon-Pennamen MD, Calvo F, Morel P. Costa da Cunha CS, et al. Among authors: rybojad m. Arch Dermatol. 1996 Mar;132(3):285-90. doi: 10.1001/archderm.132.3.285. Arch Dermatol. 1996. PMID: 8607632

8

Detection of human herpesvirus 8 and human T-cell lymphotropic virus type 1 sequences in Kaposi sarcoma.

Lebbé C, Agbalika F, de Crémoux P, Deplanche M, Rybojad M, Masgrau E, Morel P, Calvo F. Lebbé C, et al. Among authors: rybojad m. Arch Dermatol. 1997 Jan;133(1):25-30. Arch Dermatol. 1997. PMID: 9006369

9

Schönlein-Henoch purpura in adult patients. Predictive factors for IgA glomerulonephritis in a retrospective study of 57 cases.

Tancrede-Bohin E, Ochonisky S, Vignon-Pennamen MD, Flageul B, Morel P, Rybojad M. Tancrede-Bohin E, et al. Among authors: rybojad m. Arch Dermatol. 1997 Apr;133(4):438-42. doi: 10.1001/archderm.133.4.438. Arch Dermatol. 1997. PMID: 9126006

10

Frequency, clinical features and prognosis of cutaneous manifestations in adult patients with reactive haemophagocytic syndrome.

Fardet L, Galicier L, Vignon-Pennamen MD, Regnier S, Noguera ME, de Labarthe A, Raffoux E, Martinez V, Buyse S, Viguier M, Osio A, Lebbé C, Morel P, Dupuy A, Rybojad M. Fardet L, et al. Among authors: rybojad m. Br J Dermatol. 2010 Mar;162(3):547-53. doi: 10.1111/j.1365-2133.2009.09549.x. Epub 2009 Oct 10. Br J Dermatol. 2010. PMID: 19818067

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

185 results

Search Page